Arcellx Inc (ACLX)
53.20
+1.02
(+1.95%)
USD |
NASDAQ |
May 02, 16:00
53.28
+0.08
(+0.15%)
After-Hours: 20:00
Arcellx Market Cap: 2.809B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 2.809B |
| May 01, 2024 | 2.755B |
| April 30, 2024 | 2.641B |
| April 29, 2024 | 2.698B |
| April 26, 2024 | 2.741B |
| April 25, 2024 | 2.713B |
| April 24, 2024 | 2.789B |
| April 23, 2024 | 2.874B |
| April 22, 2024 | 2.745B |
| April 19, 2024 | 2.727B |
| April 18, 2024 | 2.877B |
| April 17, 2024 | 2.827B |
| April 16, 2024 | 2.915B |
| April 15, 2024 | 3.007B |
| April 12, 2024 | 3.066B |
| April 11, 2024 | 3.177B |
| April 10, 2024 | 3.119B |
| April 09, 2024 | 3.197B |
| April 08, 2024 | 3.205B |
| April 05, 2024 | 3.285B |
| April 04, 2024 | 3.274B |
| April 03, 2024 | 3.337B |
| April 02, 2024 | 3.400B |
| April 01, 2024 | 3.536B |
| March 28, 2024 | 3.672B |
| Date | Value |
|---|---|
| March 27, 2024 | 3.720B |
| March 26, 2024 | 3.703B |
| March 25, 2024 | 3.634B |
| March 22, 2024 | 3.708B |
| March 21, 2024 | 3.803B |
| March 20, 2024 | 3.880B |
| March 19, 2024 | 3.856B |
| March 18, 2024 | 3.649B |
| March 15, 2024 | 3.728B |
| March 14, 2024 | 3.673B |
| March 13, 2024 | 3.725B |
| March 12, 2024 | 3.608B |
| March 11, 2024 | 3.635B |
| March 08, 2024 | 3.820B |
| March 07, 2024 | 3.736B |
| March 06, 2024 | 3.852B |
| March 05, 2024 | 3.677B |
| March 04, 2024 | 3.585B |
| March 01, 2024 | 3.528B |
| February 29, 2024 | 3.475B |
| February 28, 2024 | 3.554B |
| February 27, 2024 | 3.570B |
| February 26, 2024 | 3.394B |
| February 23, 2024 | 3.274B |
| February 22, 2024 | 3.163B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
257.66M
Minimum
May 18 2022
3.880B
Maximum
Mar 20 2024
1.579B
Average
1.447B
Median
Dec 14 2022
Market Cap Benchmarks
| Blueprint Medicines Corp | 6.552B |
| Alnylam Pharmaceuticals Inc | 18.93B |
| Ionis Pharmaceuticals Inc | 6.286B |
| Madrigal Pharmaceuticals Inc | 4.300B |
| Vertex Pharmaceuticals Inc | 103.36B |
Market Cap Related Metrics
| PS Ratio | 23.17 |
| Price to Book Value | 5.787 |
| Price to Free Cash Flow | 13.73 |
| Price | 53.20 |
| Earnings Yield | -2.76% |